Owlstone Medical, CR UK test potential of breath test for cancer
UK diagnostics group | July 10, 2017
UK diagnostics group Owlstone Medical and Cancer Research UK have kicked off a study aiming to identify breath biomarkers to improve the early detection and diagnosis of multiple cancer types. The PAN Cancer trial will evaluate the use of Owlstone’s Breath Biopsy platform in developing breath biopsy tests for the early detection of bladder, breast, head and neck, kidney, oesophageal, pancreatic and prostate cancers and brain tumours, with the ultimate aim of speeding up diagnosis for better treatment outcomes.